Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 9:11 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 2,023 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pneumonia, Viral Clear all

Conditions: Mild-to-Moderate COVID-19
Interventions: KB109 + Self Supportive Care (SSC), Self Supportive Care (SSC) Alone; Other
Lead sponsor: Kaleido Biosciences; Industry
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 12
States / cities: Cullman, Alabama • Los Angeles, California • Rancho Cucamonga, California + 7 more

Conditions: Covid19
Interventions: COVID-19 Monitoring Using Wearable Sensors and Smartphone Technology; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 226 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: COVID-19
Interventions: At-home COVID-19 testing, Onsite COVID-19 testing; Behavioral
Lead sponsor: San Diego State University; Other
Eligibility: 2 Years and older
Enrollment: 852 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Chula Vista, California

Conditions: Covid19, Pregnancy Related, Maternal Complication of Pregnancy, Coronavirus, Neonatal Infection, Prenatal Stress, Preterm Birth
Interventions: Antibody testing for SARS-CoV-2 IgG, Testing for SARS-CoV-2 RNA, Testing for SARS-CoV-2 IgM/IgG; Diagnostic Test
Lead sponsor: Washington University School of Medicine; Other
Eligibility: Female only
Enrollment: 448 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Corona Virus Infection
Interventions: Zinc Sulfate 220 MG, Placebo; Dietary Supplement · Drug
Lead sponsor: St. Francis Hospital, New York; Other
Eligibility: 30 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Roslyn, New York

Conditions: Covid19, Diabetes
Interventions: Not listed
Lead sponsor: AdventHealth Translational Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Pulmonary Fibrosis, COVID-19 Pneumonia, Long COVID
Interventions: Sirolimus; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: SARS-CoV2 Infection
Interventions: Remdesivir; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 12 Years and older
U.S. locations: 165
States / cities: Birmingham, Alabama • Phoenix, Arizona • Fresno, California + 130 more

Conditions: Post-COVID-19 Syndrome, Postural Tachycardia Syndrome, Dysautonomia
Interventions: Non-invasive vagus nerve stimulation, Sham Intervention; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Covid19, Infectious Disease
Interventions: A $10 Survey Incentive, A $20 Survey Incentive, Emphasis of Government Involvement, Emphasis of Academic Researchers Involvement, Cost-Benefit Frame, Duty Frame, Racial/Ethnic Frame, No Messaging; Behavioral
Lead sponsor: Harvard University; Other
Eligibility: 18 Years and older
Enrollment: 561 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 10
States / cities: Bloomington, Minnesota • Columbia Heights, Minnesota • Eden Prairie, Minnesota + 5 more

Conditions: COVID-19, SARS-CoV-2
Interventions: Enoxaparin, Apixaban; Drug
Lead sponsor: Valentin Fuster; Other
Eligibility: 18 Years and older
Enrollment: 3,460 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: SARS-CoV-2 (COVID-19) Severe Pneumonia
Interventions: Efzofitimod 1 mg/kg, Efzofitimod 3 mg/kg, Placebo; Drug
Lead sponsor: aTyr Pharma, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 8
States / cities: Birmingham, Alabama • Washington D.C., District of Columbia • Miami, Florida + 5 more

Conditions: COVID-19
Interventions: Hydroxychloroquine (HCQ); Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: COVID-19, SARS-CoV 2
Interventions: Bicalutamide 150 Mg Oral Tablet; Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Covid19, SARS-CoV-2 Infection
Interventions: GC4419, Placebo; Drug
Lead sponsor: Galera Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 3
States / cities: Iowa City, Iowa • St Louis, Missouri

Conditions: COVID, Covid-19, Corona Virus Infection, Coronavirus Infection, Coronavirus-19, SARS-CoV2, SARS-CoV Infection
Interventions: Ivermectin, Doxycycline Hcl, Zinc, Vitamin D3, Vitamin C; Drug · Dietary Supplement
Lead sponsor: ProgenaBiome; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Ventura, California

Conditions: Covid-19 (SARS-CoV-2)
Interventions: Not listed
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: COVID-19
Interventions: BAT2020; Drug
Lead sponsor: Bio-Thera Solutions; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Idaho Falls, Idaho

Conditions: Quality of Life, Injection Site Reaction, Adverse Drug Event, Systemic Reaction
Interventions: mRNA COVID-19, IIV4, Placebo (saline); Biological · Other
Lead sponsor: Duke University; Other
Eligibility: 5 Years and older
Enrollment: 348 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 3
States / cities: Baltimore, Maryland • Durham, North Carolina • Cincinnati, Ohio

Conditions: Stress, Covid19, Anxiety
Interventions: Essential Oil Blend, Control Blend; Other
Lead sponsor: Nutraceuticals Research Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Franklin, Tennessee

Conditions: COVID-19
Interventions: GO2 PEEP MOUTHPIECE; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: COVID-19
Interventions: nirmatrelvir, ritonavir; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 13
States / cities: Birmingham, Alabama • Cutler Bay, Florida • DeBary, Florida + 6 more

Conditions: Cognitive Dysfunction, Covid19
Interventions: AKL-T01; Device
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: COVID-19
Interventions: PUL-042 Inhalation Solution, Placebo; Drug
Lead sponsor: Pulmotect, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 217 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 15
States / cities: Orange, California • San Bernardino, California • Coral Gables, Florida + 10 more

Search by objective public record fields.

A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function

Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology

Communities Fighting COVID Return to School

Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19

Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting

REsearching Covid-19 Outcomes in Diabetes (RECODE)

Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis

Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)

VNS for Long-COVID-19

Minnesota COVID-19 Testing Project

FREEDOM COVID-19 Anticoagulation Strategy

Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19

COVID-19 PrEP HCW HCQ Study

Trial to Promote Recovery From COVID-19 With Endocrine Therapy

A Trial of GC4419 in Patients With Critical Illness Due to COVID-19

Trial of Combination Therapy to Treat COVID-19 Infection

Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol

A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients

Simultaneous mRNA COVID-19 and IIV4 Vaccination Study

The Effect of Aromatherapy on COVID-19-induced Anxiety

Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19

A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

Improving Cognitive Health in COVID-19 Survivors

The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2